Evidence map›Paper›PMID 41432361›Full record

ArticleProtein science : a publication of the Protein Society2026

Phosphorylation of a conserved aspartate in the catalytic site of eukaryotic elongation factor 2 kinase.

Andrea Piserchio, Eta A Isiorho, Rinat Abzalimov, Kevin N Dalby, Ranajeet Ghose

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrea PiserchioDepartment of Chemistry and Biochemistry, The City College of New York, New York, New York, USA.ORCID https://orcid.org/0000-0001-7865-9065
Eta A IsiorhoMacromolecular Crystallization Facility, CUNY Advanced Science Research Center, New York, New York, USA.
Rinat AbzalimovMass Spectrometry Facility, CUNY Advanced Science Research Center, New York, New York, USA.
Kevin N DalbyDivision of Chemical Biology and Medicinal Chemistry, The University of Texas, Austin, Texas, USA.
Ranajeet GhoseDepartment of Chemistry and Biochemistry, The City College of New York, New York, New York, USA.ORCID https://orcid.org/0000-0002-0763-8686

Funding

Regulation of eEF-2K an Energy and Nutrient SensorR01GM123252 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI DALBY, KEVIN N, GHOSE, RANAJEET · 2017 to 2024
$2.7M
TimsTOF-fleX MALDI-2 mass-spectrometerS10OD036268 · OD · ADVANCED SCIENCE RESEARCH CENTER · PI ABZALIMOV, RINAT · 2024 to 2024
$1.5M
Cancer Prevention and Research Institute of Texas RP210088NIGMS NIH HHS R01 GM123252NIH HHS GM123252NIH HHS S10 OD036268U.S. Department of Energy DE-SC0012704
6 · The paper itself

Abstract

Eukaryotic elongation factor 2 kinase (eEF-2K) is a member of the α-kinase family of atypical serine/threonine kinases. eEF-2K, the only calmodulin-activated α-kinase, phosphorylates the ribosome-associated GTPase, eukaryotic elongation factor 2 (eEF-2), suppressing translational elongation. α-kinases, including eEF-2K, possess catalytic site geometries that are distinct from those of typical kinases, suggesting possible divergence in their phospho-transfer mechanisms. Unlike typical protein kinases, where chemistry is known to proceed through a sequential mechanism involving a ternary kinase-substrate-ATP•Mg

Indexed as

Aspartic AcidDictyosteliumElongation Factor 2 KinaseCatalytic DomainCrystallography, X-RayHumansModels, MolecularPhosphorylationAspartic AcidEEF2K protein, humanElongation Factor 2 Kinaseatypical protein kinasescalmodulin‐dependent kinaseelongation factor 2 kinasephospho‐transfer chemistryping‐pongsequentialtranslational regulationα‐kinases

Identifiers

PMID41432361
PMCPMC12724008

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.